ARTICLE
2 February 2023

Holland & Knight Health Dose: January 31, 2023

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences

Holland & Knight Health Doseis an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • COVID-19 Emergency Declarations End on May 11, 2023
  • House to Vote on Scaling Back COVID-19 Precautions
  • Committee Rosters Are Taking Shape
  • Conservative Push to Do Away with Income Tax and the IRS
  • HHS Releases Report on Insulin Cost Savings
  • Remote Monitoring Services Under Coverage Review
  • CMS to Crack Down on Medicare Advantage Audits
  • MACPAC Votes To Recommend Congress Let States Restrict Drug Coverage

Read the full Health Dose ยป

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More